|
1
|
Fan L, StrasserWeippl K, Li JJ, St Louis
J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM and Goss PE: Breast
cancer in China. Lancet Oncol. 15:e279–e289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kittaneh M, Montero AJ and Glück S:
Molecular profiling for breast cancer: A comprehensive review.
Biomark Cancer. 5:61–70. 2013.PubMed/NCBI
|
|
4
|
Abdelhaleem M, Maltais L and Wain H: The
human DDX and DHX gene families of putative RNA helicases.
Genomics. 81:618–622. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fuller-Pace FV: DExD/H box RNA helicases:
Multifunctional proteins with important roles in transcriptional
regulation. Nucleic Acids Res. 34:4206–4215. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Abdelhaleem M: The novel helicase
homologue DDX32 is down-regulated in acute lymphoblastic leukemia.
Leuk Res. 26:945–954. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang C, Liang X, Huang R and Zhang Z:
Up-regulation and clinical relevance of novel helicase homologue
DHX32 in colorectal cancer. J Exp Clin Cancer Res. 28:112009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Abdelhaleem M: Do human RNA helicases have
a role in cancer? Biochim Biophys Acta. 1704:37–46. 2004.PubMed/NCBI
|
|
9
|
Robert F and Pelletier J: Perturbations of
RNA helicases in cancer. Wiley Interdiscip Rev RNA. 4:333–349.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guil S, Gattoni R, Carrascal M, Abiáán J,
Stévenin J and Bach-Elias M: Roles of hnRNP A1, SR proteins, and
p68 helicase in c-H-ras alternative splicing regulation. Mol Cell
Biol. 23:2927–2941. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hönig A, Auboeuf D, Parker MM, O'Malley BW
and Berget SM: Regulation of alternative splicing by the
ATP-dependent DEAD-box RNA helicase p72. Mol Cell Biol.
22:5698–5707. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Myöhänen S and Baylin SB:
Sequence-specific DNA binding activity of RNA helicase A to the
p16INK4a promoter. J Biol Chem. 276:1634–1642. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Anderson SF, Schlegel BP, Nakajima T,
Wolpin ES and Parvin JD: BRCA1 protein is linked to the RNA
polymerase II holoenzyme complex via RNA helicase A. Nat Genet.
19:254–256. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schlegel BP, Starita LM and Parvin JD:
Overexpression of a protein fragment of RNA helicase A causes
inhibition of endogenous BRCA1 function and defects in ploidy and
cytokinesis in mammary epithelial cells. Oncogene. 22:983–991.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Alli Z, Ho M, Ackerley C and Abdelhaleem
M: Characterization of murine Dhx32. Exp Mol Pathol. 83:115–118.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin H, Liu W, Fang Z, Liang X, Li J, Bai
Y, Lin L, You H, Pei Y, Wang F and Zhang ZY: Overexpression of
DHX32 contributes to the growth and metastasis of colorectal
cancer. Sci Rep. 5:92472015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Torre LA, Bray F, Siegel RL, Ferlay J,
LortetTieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Abdelhaleem M: Helicases: An overview.
Methods Mol Biol. 587:1–12. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Abdelhaleem M: Over-expression of RNA
helicases in cancer. Anticancer Res. 24:3951–3953. 2004.PubMed/NCBI
|
|
21
|
Taunk NK, Goyal S, Wu H, Moran MS, Chen S
and Haffty BG: DEAD box 1 (DDX1) expression predicts for local
control and overall survival in early stage, node-negative breast
cancer. Cancer. 118:888–898. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Germain DR, Graham K, Glubrecht DD, Hugh
JC, Mackey JR and Godbout R: DEAD box 1: A novel and independent
prognostic marker for early recurrence in breast cancer. Breast
Cancer Res Treat. 127:53–63. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mazurek A, Luo W, Krasnitz A, Hicks J,
Powers RS and Stillman B: DDX5 regulates DNA replication and is
required for cell proliferation in a subset of breast cancer cells.
Cancer Discov. 2:812–825. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang D, Huang J and Hu Z: RNA helicase
DDX5 regulates microRNA expression and contributes to cytoskeletal
reorganization in basal breast cancer cells. Mol Cell Proteomics.
11:M111.011932. 2012. View Article : Google Scholar
|
|
25
|
Alli Z, Ackerley C, Chen Y, AlSaud B and
Abdelhaleem M: Nuclear and mitochondrial localization of the
putative RNA helicase DHX32. Exp Mol Pathol. 81:245–248. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Meng X, Liu J and Shen Z: Genomic
structure of the human BCCIP gene and its expression in cancer.
Gene. 302:139–146. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wooster R, Bignell G, Lancaster J, Swift
S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C and Micklem G:
Identification of the breast cancer susceptibility gene BRCA2.
Nature. 378:789–792. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xia W, Chen JS, Zhou X, Sun PR, Lee DF,
Liao Y, Zhou BP and Hung MC: Phosphorylation/cytoplasmic
localization of p21Cip1/WAF1 is associated with HER2/neu
overexpression and provides a novel combination predictor for poor
prognosis in breast cancer patients. Clin Cancer Res. 10:3815–3824.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dai M, AlOdaini AA, Arakelian A, Rabbani
SA, Ali S and Lebrun JJ: A novel function for p21Cip1 and
acetyltransferase p/CAF as critical transcriptional regulators of
TGFb-mediated breast cancer cell migration and invasion. Breast
Cancer Res. 14:R1272012. View
Article : Google Scholar : PubMed/NCBI
|
